These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17917650)

  • 1. Simpler tests for immune cells could transform AIDS care in Africa.
    Willyard C
    Nat Med; 2007 Oct; 13(10):1131. PubMed ID: 17917650
    [No Abstract]   [Full Text] [Related]  

  • 2. Questions about HIV causing AIDS? Viral load and T-cell (CD4) counts: why they really matter.
    AIDS Treat News; 2001 May; (364):7-8. PubMed ID: 11569964
    [No Abstract]   [Full Text] [Related]  

  • 3. Class of antiretroviral therapy and CD4+ T cell count recovery: independence questioned.
    Parienti JJ
    Clin Infect Dis; 2009 Feb; 48(3):370; author reply 370-2. PubMed ID: 19128162
    [No Abstract]   [Full Text] [Related]  

  • 4. Do CD8(+)CD25(+) cells predict immune reconstitution syndrome in HIV-positive patients who begin HAART?
    Cianchetta-Sívori M; Raso S; Fernández-Guerrero M; Górgolas M; García R
    AIDS; 2007 Nov; 21(17):2347-9. PubMed ID: 18090286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS therapy. Failure isn't what it used to be...but neither is success.
    Cohen J
    Science; 1998 Feb; 279(5354):1133-4. PubMed ID: 9508685
    [No Abstract]   [Full Text] [Related]  

  • 6. Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African national comprehensive care, treatment and management programme for HIV and AIDS.
    Glencross DK; Janossy G; Coetzee LM; Lawrie D; Aggett HM; Scott LE; Sanne I; McIntyre JA; Stevens W
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S40-51. PubMed ID: 18228554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of Toxoplasma gondii-specific immune responses in patients with AIDS starting HAART.
    Furco A; Carmagnat M; Chevret S; Garin YJ; Pavie J; De Castro N; Charron D; Derouin F; Rabian C; Molina JM
    AIDS; 2008 Oct; 22(16):2087-96. PubMed ID: 18832872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty years of HIV-1 research: what the future holds.
    Imami N; Gotch F
    Nat Immunol; 2003 Jun; 4(6):501. PubMed ID: 12774067
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV/AIDS. Experts question danger of 'AIDS superbug'.
    Cohen J
    Science; 2005 Feb; 307(5713):1185. PubMed ID: 15731415
    [No Abstract]   [Full Text] [Related]  

  • 10. Seeking a cure for AIDS.
    Laurence J
    AIDS Read; 2008 May; 18(5):228, 234. PubMed ID: 18589476
    [No Abstract]   [Full Text] [Related]  

  • 11. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
    Theze J
    Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crohn's disease, HIV, and AIDS.
    Yoshida EM; Whittaker JS
    Am J Gastroenterol; 1995 Jan; 90(1):168. PubMed ID: 7801935
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
    Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
    J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Care for HIV/AIDS during parturition].
    Veser T
    Krankenpfl Soins Infirm; 2009; 102(9):24-5. PubMed ID: 19771823
    [No Abstract]   [Full Text] [Related]  

  • 17. Maintaining reduced viral fitness and CD4 response in HIV-infected patients with viremia receiving a boosted protease inhibitor.
    Grant P; Taylor J; Cain P; Short W; Gallant J; Farthing C; Thal G; Coakley E; Zolopa A
    Clin Infect Dis; 2009 Mar; 48(5):680-2. PubMed ID: 19191657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.
    Pahwa S; Muresan P; Sleasman J; Fenton T; Moye J; Deveikis A; Wara D; Van Dyke R;
    J Allergy Clin Immunol; 2007 Jun; 119(6):1538-41. PubMed ID: 17418382
    [No Abstract]   [Full Text] [Related]  

  • 20. [Decentralization of the immunological monitoring of people living with HIV/AIDS in a limiting setting with a low HIV seroprevalence: the experience of Senegal].
    Diaw PA; Sylla Niang M; Touré Kane C; Dieye TD; Diop Ndiaye H; Wade AS; Dieye A; Mboup S
    Ann Biol Clin (Paris); 2008; 66(4):409-16. PubMed ID: 18725342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.